Carbapenemase Genes in Carbapenem-Resistant Enterobacter cloacae: Insights from Guangdong Hospitals

Study Background and Research Question

Antibiotic resistance among Gram-negative bacteria is a mounting challenge in clinical microbiology. Carbapenem-resistant Enterobacter cloacae (CREC) has emerged as a significant threat, especially in the context of increased antibiotic use and healthcare disruptions during the COVID-19 pandemic. While carbapenemase-encoding genes (CEGs) are recognized as the primary drivers of resistance in CREC, detailed regional and temporal analyses—particularly regarding their transmission dynamics—remain limited. The reference study by Chen et al. (2025) addresses this gap by characterizing the molecular epidemiology of CEGs in CREC isolates collected from eight teaching hospitals in Guangdong, China, between December 2022 and June 2024.

Key Innovation from the Reference Study

This work provides one of the first comprehensive molecular examinations of CEG carriage and transfer within CREC populations from multiple institutions in a high-prevalence region during the pandemic. Notably, the study does not merely catalog resistance genes but integrates plasmid and chromosomal localization, horizontal transfer rates, and clinical epidemiology. By dissecting both the genetic vehicles (plasmids, chromosomes, and mobile elements) and their epidemiological context, the authors offer new insight into how multidrug resistance emerges and spreads in real-world healthcare settings.

Methods and Experimental Design Insights

The research team collected 54 non-duplicate CREC isolates from eight tertiary hospitals. Key methodological features include:

• Variable temperature SDS plasmid elimination was employed to distinguish chromosomal from plasmid-borne CEGs.
• PCR and broth microdilution techniques were used to detect specific carbapenemase genes (bla_NDM-1, bla_IMP, bla_KPC-2) and to measure antibiotic susceptibility profiles.
• Plasmid conjugation assays assessed the horizontal transmissibility of resistance determinants.
• ERIC-PCR and NTSYS clustering enabled genotyping and assessment of clonal spread across hospitals.
• Analysis of mobile genetic elements (e.g., ISEcp1) to understand the genetic context of CEGs.

This multi-layered approach allowed the authors to pair molecular findings with epidemiological patterns, such as patient demographics and specimen source.

Core Findings and Why They Matter

Several consequential observations emerged from the study:

• High Prevalence of CEGs: 85.19% of CREC isolates harbored at least one carbapenemase-encoding gene, with bla_NDM-1 predominating (reference).
• Genetic Localization: bla_NDM-1 was present on both chromosomes and plasmids in 33.33% of isolates, and exclusively on plasmids in 46.30%.
• Horizontal Transfer: Plasmid conjugation experiments demonstrated a high success rate (95.65%) for CEG transfer, especially for bla_NDM-1 and bla_IMP, highlighting the ease of resistance spread.
• Mobile Genetic Elements: Six element types were found, with ISEcp1 being most prevalent (87.04%), and 40.74% of isolates carrying four distinct elements simultaneously, suggesting substantial genetic mobility.
• Multidrug Resistance: CEG-positive strains exhibited significantly higher resistance rates to key antibiotics—including imipenem, cefepime, gentamicin, ceftazidime/avibactam, ciprofloxacin, and levofloxacin—compared to CEG-negative strains.
• Epidemiological Patterns: Higher detection rates were observed in male and elderly patients, in respiratory medicine departments, and from sputum samples.

Together, these findings underscore the clinical and public health significance of CEGs in CREC, pointing to both endemic spread and the risk for rapid, plasmid-mediated resistance dissemination.

Comparison with Existing Internal Articles

Several internal resources expand on both the mechanistic and applied aspects of resistance research in Enterobacteriaceae and the use of reference antibiotics in experimental workflows:

• The article "Carbapenemase Gene Dynamics in CREC: Resistance and Epidemiology" provides a regionally focused synthesis of CEG prevalence and transmission, aligning closely with the high rates of bla_NDM-1 and mobile element diversity reported by Chen et al.
• "Levofloxacin: Mechanistic Insights and Advanced Research Utility" and related resources highlight the role of synthetic fluoroquinolone antibiotics such as levofloxacin in dissecting bacterial DNA replication pathways and resistance phenotypes. These articles detail actionable protocols for osteoblast growth inhibition assays and calcium deposition studies, which are essential for translational research linking antibiotic mechanisms to bone biology.
• The workflow-focused guide "Levofloxacin: Synthetic Fluoroquinolone Antibiotic in Research" offers detailed assay parameters and troubleshooting advice for researchers employing levofloxacin in resistance and cell-based studies.

Collectively, these resources deepen the context for interpreting the reference study’s findings—linking epidemiological surveillance to experimental design and mechanistic exploration.

Protocol Parameters

• Broth microdilution for resistance profiling: Use standardized microdilution methods as performed in the reference study to determine minimum inhibitory concentrations (MICs) for antibiotics such as levofloxacin, imipenem, and cefepime in CREC isolates.
• Plasmid elimination and conjugation assays: Employ variable temperature SDS treatment for plasmid curing, followed by conjugation experiments to assess horizontal gene transfer potential of resistance determinants.
• PCR detection of resistance genes: Design gene-specific primers for bla_NDM-1, bla_IMP, and bla_KPC-2 to confirm CEG presence and localization.
• ERIC-PCR for genotyping: Utilize ERIC-PCR and clustering software (e.g., NTSYS) to characterize strain diversity and potential hospital transmission routes.

Limitations and Transferability

While the study delivers a robust molecular and epidemiological snapshot, several limitations should be noted:

• Regional Specificity: The findings reflect CREC dynamics within Guangdong province and may not fully extrapolate to other geographies with different antibiotic stewardship policies or healthcare infrastructure.
• Hospital Sampling: All isolates were collected from teaching hospitals, which may experience different infection control pressures than community or rural healthcare settings.
• Temporal Scope: The study period (2022–2024) coincides with the COVID-19 pandemic, potentially influencing resistance patterns due to shifts in clinical practice and antibiotic usage.

Despite these caveats, the demonstrated high transferability of CEGs and the prevalence of multidrug resistance mechanisms are highly relevant for researchers and public health professionals seeking to model or mitigate resistance spread in similar settings.

Research Support Resources

For experimental workflows investigating bacterial DNA replication pathways, resistance mechanisms, or bone cell modulation, Levofloxacin (SKU B1959, APExBIO) offers a well-characterized synthetic fluoroquinolone antibiotic reference. According to the product information, levofloxacin’s known performance in osteoblast growth inhibition and calcium deposition assays, as well as its defined solubility and storage parameters, make it a practical standard for research. Researchers may find this reagent valuable in designing multidrug resistance studies or in exploring downstream effects on chondrocyte and osteoblast function, as detailed in the referenced literature.